USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/25705
Title: Management of chronic obstructive pulmonary disease associated with heart failure
Authors: Aswin, George
Keywords: Chronic obstructive pulmonary disease;heart failure
Issue Date: 2023
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: ASWIN, George. Management of chronic obstructive pulmonary disease associated with heart failure. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2023, vol. 10(3), anexa 1, p. 232. ISSN 2345-1467.
Abstract: Background. Chronic obstructive pulmonary disease (COPD) and heart failure (HF) often coexist, causing a significant burden on patients and healthcare systems. The interaction between these two conditions leads to worsened symptoms, increased hospitalizations, and reduced quality of life. Objective of the study. Assessing management strategies for COPD with heart failure to optimize patient outcomes and quality of life. Material and methods. A single case of COPD with heart failure was analyzed. Relevant medical records, diagnostic data treatment plans were reviewed. Results. A 62-year-old male patient with exacerbated COPD type B with heart failure NYHA II FC and a history of smoking for about 40 years. The patient presents with dyspnea on exertion, exercise intolerance, and exacerbations. He has a height of 175 cm, weighs 80 kg, and has a BMI of 26.1 kg/m2. His vital signs were 130/84 mmHg, 78 bpm, 21 breaths/min, and SpO2 of 91%. Pulmonary function tests indicate moderate airflow limitation, with FEV1 of 60% predicted and an FEV1/FVC ratio of 55%. Echocardiography shows a reduced ejection fraction of 40%. The patient was managed with oxygen therapy, bronchodilators, inhaled corticosteroids, diuretics, and ACE inhibitors. During the follow-up, the patient maintained stable respiratory and cardiac symptoms. Conclusions. The management of COPD associated with HF requires a multidisciplinary approach that recognizes and addresses the connection between respiratory and cardiac impairments. A comprehensive management strategy that covers both respiratory and cardiac components is essential to optimize patient outcomes, improve quality of life, and reduce the burden of this challenging comorbidity.
metadata.dc.relation.ispartof: Revista de Științe ale Sănătății din Moldova: Moldovan Journal of Health Sciences: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 18-20 octombrie 2023, Chișinău, Republica Moldova
URI: https://conferinta.usmf.md/wp-content/uploads/Culegerea-Rezumate-MJHS_10_3_2023_anexa1.pdf
http://repository.usmf.md/handle/20.500.12710/25705
ISSN: 2345-1467
Appears in Collections:Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2023 nr. 3(10) Anexa 1

Files in This Item:
File Description SizeFormat 
MJHS_10_3_2023_anexa1_232.pdf148.28 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback